Our mission is to develop and provide the tools and services that will contribute significantly to improvements in the outcomes of patient treatment and enable “precision medicine”

Technologies Designed to Improve Medical Diagnoses
and Patient Outcomes

Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in oncology, cardiology, neurology, and inherited diseases through advanced diagnostic technologies, products and services. Its ultra-sensitive ICE COLD-PCR™ powers the company’s liquid biopsy analyses that can be run on any sequencing platform to deliver a comprehensive genomic profile that includes all mutations. Transgenomic also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies.